{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:33:45Z","timestamp":1777260825763,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI168420"],"award-info":[{"award-number":["R01 AI168420"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lower respiratory tract infection (LRTI) is a leading cause of hospitalization and antibacterial use globally. In low- and middle-income countries (LMICs), limited diagnostic resources contribute to inappropriate antibacterial use for LRTI. The aim of this trial is to determine the impact of an electronic clinical decision support tool (eCDST) on LRTI management in Southern Sri Lanka.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is a prospective, open-label, stepped-wedge, cluster-randomized trial that will be conducted at three public hospitals. A total of 765 patients aged\u2009\u2265\u200914\u00a0years who are hospitalized with LRTI will be enrolled across 9 clusters; each cluster consists of a pair of wards (1 male and 1 female). The intervention consists of implementing an eCDST (RespiQuestAB) that physicians use on their mobile phones. RespiQuestAB integrates real-time influenza incidence in Sri Lanka with epidemiological and clinical predictors of LRTI etiology to estimate the probability of the following diagnoses: influenza, other viral (including SARS-CoV-2) infection, bacterial infection, noninfectious condition, or indeterminate. Point-of-care (POC) tests for influenza, SARS-CoV-2,\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      , or procalcitonin are recommended if a positive result increases the probability of the associated diagnosis by at least 5%; clinicians may also order these tests independently. RespiQuestAB provides treatment recommendations regarding antibacterial and antiviral (oseltamivir) use based on the probability of diagnosis. Participants will be followed longitudinally to assess antibacterial prescription and clinical outcomes.\n                    <\/jats:p>\n                    <jats:p>The co-primary outcomes are as follows: (1) Duration of antibacterial prescription for the index visit and (2) a composite clinical outcome associated with worsening LRTI by day 30. Secondary outcomes include the individual clinical outcomes of the composite outcome, receipt, and duration of antibacterial and antiviral prescriptions and physician adherence to diagnostic tests and treatments recommended by RespiQuestAB. Exploratory outcomes include Desirability of Outcome Ranking (DOOR) level arranged in an ordinal scale, individual DOOR levels, and prescription of immunomodulatory therapy for SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Results of this clinical trial will provide information on the impact of the RespiQuestAB on antibacterial use and clinical outcomes among patients with LRTI in an LMIC setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT06331364. Registered on March 25, 2024.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-026-09628-0","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:46:22Z","timestamp":1773841582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): study protocol for a stepped-wedge, cluster-randomized clinical trial"],"prefix":"10.1186","volume":"27","author":[{"given":"P. D. W. D.","family":"De Zoysa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Weerasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Iglesias-Ussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Olague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Obale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Gallis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Palangasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Senadheera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vasana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. K.","family":"Bodinayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D. S.","family":"Nagahawatte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. M. D. G. B.","family":"Wijayaratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R. P.","family":"Kurukulasooriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Premamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. H. B. Y.","family":"Dilshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ngocho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"\u00d8stbye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. B.","family":"Laber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Naggie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-7271","authenticated-orcid":false,"given":"L. G.","family":"Tillekeratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"11","key":"9628_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","volume":"17","author":"C Troeger","year":"2017","unstructured":"Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A, Swartz S, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17(11):1133\u201361.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"9628_CR2","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","volume":"6","author":"A Versporten","year":"2018","unstructured":"Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an Internet-based global point prevalence survey. Lancet Glob Heal. 2018;6(6):e619\u201329.","journal-title":"Lancet Glob Heal"},{"issue":"SUPPL. 4","key":"9628_CR3","first-page":"0","volume":"52","author":"AT Pavia","year":"2011","unstructured":"Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis. 2011;52(SUPPL. 4):0\u20135.","journal-title":"Clin Infect Dis"},{"issue":"10200","key":"9628_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","volume":"394","author":"KL O\u2019Brien","year":"2019","unstructured":"O\u2019Brien KL, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Higdon MM, et al. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019;394(10200):757\u201379.","journal-title":"Lancet"},{"issue":"12","key":"9628_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057\u201398.","journal-title":"Lancet Infect Dis"},{"issue":"10053","key":"9628_CR6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"H Wang","year":"2016","unstructured":"Wang H, Naghavi M, Allen C, Barber RM, Carter A, Casey DC, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459\u2013544.","journal-title":"Lancet"},{"issue":"4 SUPPL.","key":"9628_CR7","first-page":"415","volume":"5","author":"VT Andriole","year":"2015","unstructured":"Andriole VT. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;5(4 SUPPL.):415\u201327.","journal-title":"N Engl J Med"},{"key":"9628_CR8","doi-asserted-by":"crossref","unstructured":"Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children and for the Centers for Disease Control and Prevention (CDC) Etiology of Pneumonia in the Community (EPIC) Study Team. N Engl J Med. 2015;372(9):835\u201345.","DOI":"10.1056\/NEJMoa1405870"},{"issue":"1","key":"9628_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4269\/ajtmh.16-0733","volume":"97","author":"T Ben\u00e9t","year":"2017","unstructured":"Ben\u00e9t T, Picot VS, Awasthi S, Pandey N, Bavdekar A, Kawade A, et al. Severity of pneumonia in under 5-year-old children from developing countries: a multicenter, prospective, observational study. Am J Trop Med Hyg. 2017;97(1):68\u201376.","journal-title":"Am J Trop Med Hyg"},{"key":"9628_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304690","author":"PG Medrano","year":"2024","unstructured":"Medrano PG, Weerasinghe N, Nagahawatte A, Vanderburg S, Park LP, Wijayaratne GB, et al. Prevalence and predictors of antibiotic prescription among patients hospitalized with viral lower respiratory tract infections in Southern Province, Sri Lanka. PLoS One. 2024. https:\/\/doi.org\/10.1371\/journal.pone.0304690.","journal-title":"PLoS One"},{"issue":"2","key":"9628_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1017\/ice.2018.321","volume":"40","author":"T Sheng","year":"2019","unstructured":"Sheng T, Wijayaratne GB, Dabrera TM, Drew RJ, Nagahawatte A, Bodinayake CK, et al. Point-prevalence study of antimicrobial use in public hospitals in Southern Sri Lanka identifies opportunities for improving prescribing practices. Infect Control Hosp Epidemiol. 2019;40(2):224\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"9628_CR12","unstructured":"O'Neill, J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. Review on Antimicrobial Resistance. 2014. https:\/\/amr-review.org\/."},{"issue":"12","key":"9628_CR13","doi-asserted-by":"publisher","first-page":"e1928","DOI":"10.1016\/S2214-109X(24)00418-2","volume":"12","author":"AS Ginsburg","year":"2024","unstructured":"Ginsburg AS, Duncan K, Klugman KP, Srikantiah P. Access to antibiotics for pneumonia and sepsis in LMICs. Lancet Glob Health. 2024;12(12):e1928-9. https:\/\/doi.org\/10.1016\/S2214-109X(24)00418-2.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"9628_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/adc.88.6.525","volume":"88","author":"S Esposito","year":"2003","unstructured":"Esposito S, Marchisio P, Morelli P, Crovari P, Principi N. Effect of a rapid influenza diagnosis. Arch Dis Child. 2003;88(6):525\u20136.","journal-title":"Arch Dis Child"},{"issue":"2","key":"9628_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1542\/peds.112.2.363","volume":"112","author":"AB Bonner","year":"2003","unstructured":"Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision- making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics. 2003;112(2):363\u20137.","journal-title":"Pediatrics"},{"issue":"4","key":"9628_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijid.2006.09.009","volume":"11","author":"D Bhavnani","year":"2007","unstructured":"Bhavnani D, Phatinawin L, Chantra S, Olsen SJ, Simmerman JM. The influence of rapid influenza diagnostic testing on antibiotic prescribing patterns in rural Thailand. Int J Infect Dis. 2007;11(4):355\u20139.","journal-title":"Int J Infect Dis"},{"key":"9628_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jcv.2018.09.009","volume":"108","author":"M Echavarr\u00eda","year":"2018","unstructured":"Echavarr\u00eda M, Marcone DN, Querci M, Seoane A, Ypas M, Videla C, et al. Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection. J Clin Virol. 2018;108:90\u20135. https:\/\/doi.org\/10.1016\/j.jcv.2018.09.009.","journal-title":"J Clin Virol"},{"issue":"5","key":"9628_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4269\/ajtmh.15-0269","volume":"93","author":"LG Tillekeratne","year":"2015","unstructured":"Tillekeratne LG, Bodinayake CK, Nagahawatte A, Vidanagama D, Devasiri V, Arachchi WK, et al. Use of rapid influenza testing to reduce antibiotic prescriptions among outpatients with influenza-like illness in Southern Sri Lanka. Am J Trop Med Hyg. 2015;93(5):1031\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"9628_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.molmed.2014.08.001","volume":"20","author":"AK Zaas","year":"2014","unstructured":"Zaas AK, Garner BH, Tsalik EL, Burke T, Woods CW, Ginsburg GS. The current epidemiology and clinical decisions surrounding acute respiratory infections. Trends Mol Med. 2014;20(10):579\u201388.","journal-title":"Trends Mol Med"},{"issue":"3","key":"9628_CR20","first-page":"239","volume":"14","author":"PK Drain","year":"2014","unstructured":"Drain PK, Hyle EP, Noubary F, Freedberg KA, Wilson D, Bishai W, et al. Evaluating diagnostic point-of-care tests in resource-limited settings. 2014;14(3):239\u201349.","journal-title":"Evaluating diagnostic point-of-care tests in resource-limited settings"},{"key":"9628_CR21","doi-asserted-by":"crossref","unstructured":"Zumla A, Al-Tawfiq JA, Enne VI, et al. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections\u2014needs, advances, and future prospects.\u00a0Lancet Infect Dis. 2014;14(11):1123\u201335.","DOI":"10.1016\/S1473-3099(14)70827-8"},{"key":"9628_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002396","author":"C Escadafal","year":"2020","unstructured":"Escadafal C, Incardona S, Fernandez-Carballo BL, Dittrich S. The good and the bad: using C reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings. BMJ Glob Health. 2020. https:\/\/doi.org\/10.1136\/bmjgh-2020-002396.","journal-title":"BMJ Glob Health"},{"key":"9628_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa260","author":"J van Griensven","year":"2020","unstructured":"van Griensven J, Cnops L, de Weggheleire A, Declercq S, Bottieau E. Point-of-care biomarkers to guide antibiotic prescription for acute febrile illness in sub-Saharan Africa: promises and caveats. Open Forum Infect Dis. 2020. https:\/\/doi.org\/10.1093\/ofid\/ofaa260.","journal-title":"Open Forum Infect Dis"},{"key":"9628_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-1-4939-1776-1_16","volume":"1237","author":"JL Vincent","year":"2014","unstructured":"Vincent JL, Van Nuffelen M, Lelubre C. Host response biomarkers in sepsis: the role of procalcitonin. Methods Mol Biol. 2014;1237:213\u201324.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"9628_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/infdis\/jiv032","volume":"212","author":"EL Tsalik","year":"2015","unstructured":"Tsalik EL, McClain M, Zaas AK. Moving toward prime time: host signatures for diagnosis of respiratory infections. J Infect Dis. 2015;212(2):173\u20135.","journal-title":"J Infect Dis"},{"issue":"3","key":"9628_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MCP.0000000000000669","volume":"26","author":"P P\u00f3voa","year":"2020","unstructured":"P\u00f3voa P, Coelho L, Bos DJ. New biomarkers for respiratory infections. Curr Opin Pulm Med. 2020;26(3):232\u201340.","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"9628_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0160278","volume":"11","author":"AJ Kapasi","year":"2016","unstructured":"Kapasi AJ, Dittrich S, Gonz\u00e1lez IJ, Rodwell TC. Host biomarkers for distinguishing bacterial from non-bacterial causes of acute febrile illness: a comprehensive review. PLoS One. 2016;11(8):1\u201329.","journal-title":"PLoS One"},{"key":"9628_CR28","unstructured":"World Health Organization. Integrated management of childhood illness global survey report. Geneva: WHO. 2017"},{"key":"9628_CR29","unstructured":"World Health Organization (WHO). IMAI District Clinician Manual\u202f: Hospital Care for Adolescents and Adults. World Heal Organ. 2011;2:780. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/77751\/3\/9789241548290_Vol2_eng.pdf?ua=1."},{"issue":"9692","key":"9628_CR30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0140-6736(09)61452-5","volume":"374","author":"E Mason","year":"2009","unstructured":"Mason E, Scherpbier R, Lawe-Davies O. WHO position statement on IMCI. Lancet. 2009;374(9692):782\u20133.","journal-title":"Lancet"},{"issue":"2","key":"9628_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.4269\/ajtmh.14-0496","volume":"92","author":"MP Rubach","year":"2015","unstructured":"Rubach MP, Maro VP, Bartlett JA, Crump JA. Etiologies of illness among patients meeting Integrated Management of Adolescent and Adult Illness District Clinician Manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapy. Am J Trop Med Hyg. 2015;92(2):454\u201362.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"9628_CR32","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1016\/S2214-109X(20)30079-6","volume":"8","author":"G Allwell-Brown","year":"2020","unstructured":"Allwell-Brown G, Hussain-Alkhateeb L, Kitutu FE, Str\u00f6mdahl S, M\u00e5rtensson A, Johansson EW. Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005\u201317: a systematic analysis of 132 national surveys from 73 countrie. Lancet Glob Heal. 2020;8(6):e799-807.","journal-title":"Lancet Glob Heal"},{"issue":"11","key":"9628_CR33","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/cid\/ciz665","volume":"70","author":"S Pokharel","year":"2020","unstructured":"Pokharel S, White LJ, Aguas R, Celhay O, Pell\u00e9 KG, Dittrich S. Algorithm in the diagnosis of febrile illness using pathogen-specific rapid diagnostic tests. Clin Infect Dis. 2020;70(11):2262\u20139.","journal-title":"Clin Infect Dis"},{"key":"9628_CR34","doi-asserted-by":"publisher","unstructured":"Olliaro P, Nkeramahame J, Horgan P, Tinto H, Kiemde F, Baiden R, et al. Synthesis and meta-analysis of 3 randomized trials conducted in Burkina Faso, Ghana, and Uganda comparing the effects of point-of-care tests and diagnostic algorithms versus routine care on antibiotic prescriptions and clinical outcomes in ambulatory pati. Clin Infect Dis. 2023;77(Suppl 2):S199\u2013205. Available from: https:\/\/doi.org\/10.1093\/cid\/ciad324.","DOI":"10.1093\/cid\/ciad324"},{"issue":"6","key":"9628_CR35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.4269\/ajtmh.24-0126","volume":"111","author":"LG Tillekeratne","year":"2024","unstructured":"Tillekeratne LG, De Soyza W, Iglesias-Ussel MD, Olague S, Palangasinghe D, Nagahawatte A, et al. Electronic clinical decision support tools: strategies to improve the management of lower respiratory tract infections in low-resource settings. Am J Trop Med Hyg. 2024;111(6):1173\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"9628_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1002411","volume":"14","author":"K Keitel","year":"2017","unstructured":"Keitel K, Kagoro F, Samaka J, Masimba J, Said Z, Temba H, et al. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): a randomized, controlled non-inferiority trial. PLoS Med. 2017;14(10):1\u201329.","journal-title":"PLoS Med"},{"issue":"5","key":"9628_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/cid\/cis464","volume":"55","author":"P Schuetz","year":"2012","unstructured":"Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;55(5):651\u201362.","journal-title":"Clin Infect Dis"},{"key":"9628_CR38","doi-asserted-by":"crossref","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. https:\/\/pubmed.ncbi.nlm.nih.gov\/23303884\/.","DOI":"10.1136\/bmj.e7586"},{"key":"9628_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2021.106522","author":"J Chen","year":"2022","unstructured":"Chen J, Zhou X, Li F, Spiegelman D. Swdpwr: a SAS macro and an R package for power calculations in stepp","journal-title":"Comput Methods Programs Biomed"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09628-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09628-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09628-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:49:29Z","timestamp":1777258169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09628-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9628"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09628-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee, Faculty of Medicine, University of Ruhuna, Sri Lanka (Reference no. 2023\/P\/113) on 19th October 2023. Written, informed consent will be obtained from all adult patients and the parents or guardians of patients 14\u201317\u00a0years of age. Assent will be obtained from patients 14\u201317\u00a0years of age. Informed consent forms were approved by the Ethical Review Committee, Faculty of Medicine, University of Ruhuna, IRB-Duke University, SLCTR, and ET&R and will be used in the trial. Informed consent forms can be provided by the principal investigator upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no personal, financial, or institutional interest in any of the materials or devices being used in this trial.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}